- Home
- ORKA vs WERN Comparison
ORKA vs WERN Comparison
Compare ORKA & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ORKA | WERN |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | ORKA | WERN |
|---|---|---|
| Price | $69.81 | $33.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 14 |
| Target Price | ★ $73.33 | $31.07 |
| AVG Volume (30 Days) | ★ 1.2M | 875.8K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,974,396,000.00 |
| Revenue This Year | N/A | $21.27 |
| Revenue Next Year | N/A | $6.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.91 | $23.02 |
| 52 Week High | $70.14 | $38.45 |
Technical Indicators
Market Signals| Indicator | ORKA | WERN |
|---|---|---|
| Relative Strength Index (RSI) | 78.44 | 65.12 |
| Support Level | $26.02 | $31.85 |
| Resistance Level | N/A | $35.39 |
| Average True Range (ATR) | 3.83 | 1.16 |
| MACD | 0.92 | 0.41 |
| Stochastic Oscillator | 95.03 | 96.61 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company engaged in transporting truckload shipments of general commodities in both interstate and intrastate commerce. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.